SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Far below the surface, where light no longer reaches and noise collapses into silence, the Sperm Whale endures.  It does not rely on speed or spectacle. It survives through mass, intelligence, and absolute awareness of its surroundings.  This project is shaped by the same principle — strength formed under pressure, movement guided by understanding, and conviction built where others cannot remain.  While the surface reacts, the deep decides.

The Sperm Whale

SPERMWHALE is trending as investors debate its potential as a high-volatility meme coin, with some highlighting rapid gains and accumulation patterns while others dismiss it as a pump-and-dump scheme. Community conversation is split between those aggressively promoting the coin's momentum on platforms like Phantom and Coinbase and skeptics warning of significant risks associated with the asset's low liquidity and suspicious origin.

Fundrise Innovation Fund LLC. - Common Shares of Limited Liability Company Interests

Fundrise Innovation Fund 

VCX is trending as investors react to its recent NYSE listing and the unique opportunity to gain liquid exposure to a basket of high-profile private tech companies like Anthropic, SpaceX, and OpenAI. The community is intensely debating the stock's significant premium over its net asset value, the impact of a six-month lockup period restricting many early holders, and the potential for extreme volatility driven by a small tradable float.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

Gorilla Technology is trending following the announcement of a $500 million AI infrastructure deal with Yotta Data Services, which the community sees as major validation of the company's ability to execute on its massive project pipeline. Investors are intensely debating the firm's long-term potential versus concerns regarding share dilution, communication transparency, and the stock's persistent price decline.

Apollo Global Management, Inc. provides asset management services. It offers its clients excess return at every point along the risk-reward spectrum from investment grade to private equity with a focus on three business strategies: yield, hybrid, and equity. It operates through following segments: Asset Management, Retirement Services and Principal Investing. The Asset Management segment focuses on credit and equity investing strategies. The Retirement Services and Principal Investing segment consists of realized performance fee income, realized investment income from balance sheet investments, and certain allocable expenses related to corporate functions supporting the entire company. The company was founded by Marc Rowan in 1990 and is headquartered in New York, NY.

Apollo Global Management Inc

Apollo Global Management is currently trending due to its pivotal role as a major player in private credit and infrastructure, with ongoing market focus on its expanding AUM and strategic investments. Investors are closely monitoring the firm's leadership in high-stakes financing and its broader integration into market benchmarks, while community discussions emphasize the balance between its aggressive growth strategy and the macroeconomic risks associated with the private debt sector.

Robinhood Ventures Fund I invest in companies located in the United States. The fund focuses on a broad range of sectors and industries. It provides financing for early stage transactions.

Robinhood Ventures Fund I - Common shares of beneficial interest

Robinhood Ventures Fund I is currently under intense community scrutiny as investors express frustration over its lackluster debut and a significant gap between its IPO pricing and current trading levels. While some participants are holding for long-term exposure to the fund's private tech holdings, others are actively drawing negative comparisons to newer market entries, fueling a heated debate over valuation, liquidity, and Robinhood's execution of these private market products.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals is currently trending following speculative reports from Betaville suggesting the company is a potential target for a multi-billion dollar M&A deal. While retail investors remain cautiously optimistic about a buyout, community discussions are heavily focused on high short interest and the stock's recent volatility as traders debate the credibility of these unconfirmed reports versus the company's long-term commercial potential.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Celsius is experiencing a significant sell-off despite strong financial performance, leading to intense community debate over whether the decline is caused by broader market volatility, technical gap filling, or potential manipulation linked to a long-term strategy for a PepsiCo acquisition. While many investors are frustrated by the relentless price drop and management's communication, others see the current levels as a deep value opportunity to load up on a dominant energy brand ahead of projected summer growth.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is seeing intense volatility as the community debates whether the stock is being intentionally suppressed by market makers through manipulation or if it is simply cooling off after a parabolic run. While retail investors remain frustrated by the stock's performance relative to its strong earnings and AI-driven HBM demand, many are looking to the upcoming S&P 100 inclusion and potential institutional accumulation as catalysts for a long-term breakout.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is facing significant selling pressure as investors grapple with technical weakness and sentiment shifts, leading to intense community debate over whether the current pullback represents a generational buying opportunity or a deeper correction. Market participants are actively scrutinizing the stock's relative underperformance compared to other mega-cap tech peers, while skepticism regarding AI-driven monetization and capacity constraints continues to fuel bearish volume and option-related volatility.

The Walt Disney Co. engages in the business of international family entertainment and media enterprise. It owns and operates television and radio production, distribution and broadcasting stations, direct-to-consumer services, amusement parks, and hotels. It operates through the following business segments: Disney Entertainment, ESPN, and Disney Parks, Experiences, and Products. The company was founded by Walter Elias Disney on October 16, 1923 and is headquartered in Burbank, CA.

Walt Disney Co (The)

Walt Disney Co

Disney is currently the center of investor attention following the appointment of parks chief Josh D'Amaro as the new CEO, sparking debate over whether this leadership transition will finally resolve long-standing stock stagnation and valuation concerns. While some in the community see the move as a catalyst for a turnaround supported by strong theme park revenue, others remain skeptical, citing continued concerns over legacy media performance and the effectiveness of current growth strategies.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

RGNX DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds REGENXBIO (RGNX) Investors of Securities Class Action Deadline on April 14, 2026

RGNX DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds REGENXBIO (RGNX) Investors of Securities Class Action Deadline on April 14, 2026 RGNX DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds REGENXBIO (RGNX...

REGENXBIO Inc. $RGNX Shares Bought by JPMorgan Chase & Co.

JPMorgan Chase & Co. increased its holdings in REGENXBIO Inc. (NASDAQ:RGNX - Free Report) by 4.8% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,037,248 shares of the biotechnology company's stock...

OCGN Gene-Agnostic Eye Therapy Could Shift Retinal Drug Development

OCGN's gene-agnostic eye therapy aims to treat multiple retinal mutations, with key filings and pivotal data in 2026???2027 set to test its broad platform.

OCGN Gene Therapy Pipeline: 2026-2027 Catalysts To Watch

Ocugen lines up key gene therapy catalysts through 2027, with pivotal data, filings, and milestones across three eye programs set to drive stock volatility.

Ocugen Stock Outlook: Balancing Cash Burn and Late-Stage Data

Ocugen faces rising cash burn and dilution risk as it advances late-stage gene therapy programs, with 2026-2027 data and filings set to drive volatility.

RGNX Investors Have Opportunity to Lead REGENXBIO, Inc. Securities Fraud Lawsuit

RGNX Investors Have Opportunity to Lead REGENXBIO, Inc. Securities Fraud Lawsuit RGNX Investors Have Opportunity to Lead REGENXBIO, Inc. Securities Fraud Lawsuit PR Newswire NEW YORK, March 19, 2026...

REGENXBIO, Inc. Stockholders Should Contact Robbins LLP for Information About Leading the RGNX Class Action

Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired REGENXBIO, Inc. (NASDAQ: RGNX) securities between February 9, 2022 and...

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in REGENXBIO Inc. of Class Action Lawsuit and Upcoming Deadlines - RGNX

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in REGENXBIO Inc. of Class Action Lawsuit and Upcoming Deadlines - RGNX INVESTOR ALERT: Pomerantz Law Firm Reminds...

STEPHEN PAKOLA OVERSAW RGX-111 SAFETY CLAIMS THAT COST RGNX INVESTORS MILLIONS: SUEWALLST, LLP

STEPHEN PAKOLA OVERSAW RGX-111 SAFETY CLAIMS THAT COST RGNX INVESTORS MILLIONS: SUEWALLST, LLP STEPHEN PAKOLA OVERSAW RGX-111 SAFETY CLAIMS THAT COST RGNX INVESTORS MILLIONS: SUEWALLST, LLP PR...

RGNX SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds REGENXBIO (RGNX) Investors of Securities Class Action Deadline on April 14, 2026

RGNX SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds REGENXBIO (RGNX) Investors of Securities Class Action Deadline on April 14, 2026 RGNX SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP...

REGENXBIO, Inc. is a clinical-stage biotechnology company, which engages in the development, commercialization, and licensing of recombinant adeno-associated virus gene therapy. Its product candidates include the NAV Technology Platform, which consists of exclusive rights to novel adeno-associated viral vectors, and therapeutic programs such as RGX-314, RGX-202, RGX-121, RGX-111, RGX-181, and RGX-381. The company was founded by Kenneth T. Mills and James M. Wilson on July 16, 2008 and is headquartered in Rockville, MD.

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	-$1.34	--	--	N/A
Q4 '25	-$0.88	-$1.30	-48.52%	MISSED
Q3 '25	-$1.30	-$1.20	7.81%	BEAT
Q2 '25	-$0.94	-$1.38	-47.14%	MISSED
Q1 '25	$0.46	$0.12	-73.93%	MISSED

RGNX
Regenxbio Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q4 '25

Historical Earnings

Latest RGNX News

RGNXRegenxbio Inc